Leflunomide/teriflunomide inhibit Epstein-Barr virus (EBV)-induced lymphoproliferative disease and lytic viral replication

EBV infection causes mononucleosis and is associated with specific subsets of B cell lymphomas. Immunosuppressed patients such as organ transplant recipients are particularly susceptible to EBV-induced lymphoproliferative disease (LPD), which can be fatal. Leflunomide (a drug used to treat rheumatoi...

詳細記述

保存先:
書誌詳細
出版年:Oncotarget
主要な著者: Bilger, Andrea, Plowshay, Julie, Ma, Shidong, Nawand ar, Dhananjay, Barlow, Elizabeth A., Romero-Masters, James C., Bristol, Jillian A., Li, Zhe, Tsai, Ming-Han, Delecluse, Henri-Jacques, Kenney, Shannon C.
フォーマット: Artigo
言語:Inglês
出版事項: Impact Journals LLC 2017
主題:
Research Paper
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5546479/
https://ncbi.nlm.nih.gov/pubmed/28574826
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.17863
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料